Add BrightSurf on Google Email

A crystal ball for brain cancer?

UCLA researchers developed a new way to scan brain tumors and predict which ones will respond to the drug Avastin before treatment. By linking high water movement in tumors to positive drug response, they predicted with 70 percent accuracy which patients' tumors were the least likely to grow six months after therapy.

DNA variations linked to brain tumors

Researchers at Mayo Clinic and University of California San Francisco have discovered a connection between DNA alterations on human chromosome 9 and glioblastoma. The study found that individuals with specific single nucleotide polymorphisms (SNPs) are 50% more likely to develop the aggressive brain cancer.

SourceMayo Clinic·JournalNature Genetics·DateJul 5, 2009

Potential for noninvasive brain tumor treatment

Researchers design a minimally invasive system combining ultrasound and chemotherapy to target brain tumors without surgery or radiation. The approach aims to provide real-time imaging and localized temperature increases to melt liposome shells and release chemotherapy directly to the tumor.

Tumor growth and chemo response may be predicted by mathematical model

A new mathematical model developed at the University of Texas Health Science Center at Houston suggests that tumor growth and invasion can be predicted using biophysical laws. The model, which links molecular and cellular properties to tumor behavior, consistently reproduced patterns of tumor invasion observed in experiments and patien...

Bone marrow stem cell co-transplantation prevents embryonic stem cell transplant-associated tumors

Co-transplanting bone marrow stem cells with embryonic stem cells eliminates tumor formation in spinal cord injury (SCI) laboratory animals. The study suggests that BMSCs induce differentiation of undifferentiated ES cells into a neuronal lineage, resulting in suppression of tumor growth.

Study finds biological clue in brain tumor development

Scientists at The University of Nottingham have uncovered a vital new biological clue that could lead to more effective treatments for CNS PNETs, a type of brain tumour predominantly occurring in children. The research found that WNT pathway activation is linked to patient survival and may represent an important new target for treatment.

SourceUniversity of Nottingham·JournalBritish Journal of Cancer·DateMar 18, 2009

Brain tumors: New therapy surprisingly successful

Researchers at Bonn University discovered a critical improvement in treating glioblastoma, the most aggressive and common brain tumor. The combination of two drugs increased average survival time to 23 months, with some patients surviving over four years. Further investigations are needed to optimize this therapy.

SourceUniversity of Bonn·JournalJournal of Clinical Oncology·DateMar 6, 2009

MR spectroscopy may help avoid invasive procedures and treatments for recurrent brain lesions

A clinical decision model using MR spectroscopy can help patients avoid unnecessary biopsies and treatments by identifying whether a new lesion is due to a recurrent tumor or post-radiation changes. The technique analyzes ratios of three metabolites, including choline, creatine, and NAA, to determine the likelihood of a recurrent tumor.

SourceAmerican College of Radiology·JournalAmerican Journal of Roentgenology·DateFeb 2, 2009

Do cell phones increase brain cancer risk?

Recent studies suggest a possible link between long-term cell phone use and increased risk of brain tumors, prompting a call for collaborative research initiatives. Scientists emphasize the need for definitive evidence to determine the risks associated with electromagnetic field exposure from cell phones.

SourceElsevier·JournalSurgical Neurology·DateOct 20, 2008

Parsing the genome of a deadly brain tumor

The study identifies frequently mutated genes, including ERBB2 and NF1, which were previously underestimated in their role in glioblastoma. The analysis also provides a wide view of how cell pathways are altered during the initiation and growth of glioblastoma, offering insights into strategies to diagnose and treat the disease.

SourceBaylor College of Medicine·JournalNature·DateSep 4, 2008